Literature DB >> 14553880

Coronary artery bypass surgery is still cost-effective: using calibrated models to update clinical trials.

Milton C Weinstein.   

Abstract

Mesh：

Year:  2003        PMID： 14553880     DOI： 10.1016/s0002-9343(03)00437-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  1 in total

Review 1.  Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia.

Authors:  Shelby D Reed; Kevin J Anstrom; Yanhong Li; Kevin A Schulman
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.